A collaborative team of researchers, including Dr. Stephan Grupp, recently presented preliminary data showing that a CRISPR-based gene-editing therapy for inherited blood disorders is safe and effective.

There are many reasons why patients miss taking doses of medications. These 10 tips can help.

Children’s Hospital of Philadelphia is proud to announce that Garrett Brodeur, MD, has been honored with the Distinguished Career Award from the American Society of Pediatric Hematology/Oncology (ASPHO).

CHOP announced that Citadel Credit Union has renewed its partnership for an additional three years as the presenting sponsor of CHOP’s annual Parkway Run & Walk.

CHOP researchers will use optical coherence tomography (OCT) to measure vision changes associated with NF1-related optic pathway gliomas.

The Division of Oncology at Children’s Hospital of Philadelphia (CHOP) has appointed Sarah Tasian, MD, as Chief of the Section of Hematologic Malignancies.

The treatment modifies a domain in the CAR that targets CD19, making it look more human and therefore less likely to be rejected by patients.

On May 28, Dr. Stephan Grupp was featured on The Doctors to discuss the latest in CAR-T cell therapy and how it is changing the future of cancer care.

CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.

CHOP researchers have found that MN1 overexpression leads to stabilization of the BAF complex, which leads to overproduction of progenitor and stem cells.